Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory diseaseAlfredo Berruti, Luigi Dogliotti, Enrico Bollito et al.|Endocrine Related Cancer|2005Cited by 136
Reassessing the Current TNM Lymph Node Staging for Renal Cell CarcinomaCarlo Terrone, S. Rocca Rossétti, Cecilia Maria Cracco et al.|European Urology|2005Cited by 99
Chromogranin A Expression in Patients With Hormone Naïve Prostate Cancer Predicts the Development of Hormone Refractory DiseaseAlfredo Berruti, Luigi Dogliotti, Alessandra Mosca et al.|The Journal of Urology|2007Cited by 89
First long-term results on efficacy and safety of long-acting pasireotide in combination with everolimus in patients with advanced carcinoids (NET) of the lung/thymus: Phase II LUNA trial.Éric Baudin, Piero Ferollà, Alfredo Berruti et al.|Journal of Clinical Oncology|2021Cited by 7